DOGP
Dogecoin Cash, Inc., through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. It also develops Lozenges for relief; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC, as well as intends to offer hi branded men's and women's fashion from suppliers through its www.cbds.com website. In addition, the company holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and cannabis industries. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.00 | $192,898 | -$13,443 |
| 2025 Q4 | 0.07 | $171,406 | -$2,925 |
| 2025 Q3 | -0.00 | $190,564 | -$41,866 |
| 2025 Q2 | -0.00 | $192,464 | $1,079 |
| 2025 Q1 | -0.07 | $184,473 | $4,129 |
| 2024 Q4 | -0.01 | $154,061 | -$29,270 |
| 2024 Q3 | -0.00 | $189,121 | -$15,591 |
| 2024 Q2 | -0.00 | $234,391 | -$212,560 |